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The presence of vitamin K-dependent carboxylase was investigated in the microsomal fraction of 20 
different types of bovine tissue. Except for muscle, veins, lymphocytes and bone membrane, carboxylase 
was found in all these preparations, albeit in varying amounts. No differences could be detected between 
these carboxylating systems with respect to their affinity for vitamin K and warfarin. Most of the 
endogenous ubstrates had some affinity towards antiprothrombin or antifactor X. 
Carboxylase Vitamin K Warfarin Liver y-carboxyglumatic acid 
1. INTRODUCTION England Nuclear. All other chemicals were ob- 
tained from Merck. 
Vitamin K-dependent carboxylase has been de- 
tected in the liver of a wide variety of species, in- 
cluding man (l-31. In the first years after its dis- 
covery, this carboxylase was thought to be unique- 
ly involved in the synthesis of blood clotting fac- 
tors, and hence it was supposed to be located in the 
liver exclusively. During the last few years, how- 
ever, a number of investigators has reported the 
presence of vitamin K-dependent carboxylase in 
non-hepatic tissues, such as kidney, spleen, lung 
and bone [4-61. The importance of these non- 
hepatic carboxylases remained obscure until now, 
because in most cases: (a) the reaction products 
could not be identified; and (b) the relative 
amounts of these carboxylating systems were not 
compared with the amounts of enzyme present in 
hepatic tissue. Here, we describe experiments by 
which we try to make an inventory of the carboxyl- 
ating systems in different types of bovine tissue. 
2.2. Preparation of washed microsomes 
Soft tissues were homogenized and used for the 
preparation of crude microsomes as in 121. The mi- 
crosomes were washed 3 times with a buffer con- 
taining 30% ethylene glycol, 0.8 M KC1 and 0.02 M 
Tris-HCl (pH 7.4). Arteries, veins, bone mem- 
brane and tendon were frozen in liquid nitrogen, 
crushed to powder and subsequently homogenized 
in the same buffer. Bone and cartilage were 
powdered in a similar way, extracted with a buffer 
containing 0.1 M EDTA, 0.8 M KC1 and 0.02 M 
Tris-HCl (pH 7.8) and the extracts were homoge- 
nized as described for the soft tissues. 
2.3. Measurement of carboxylase activity 
The vitamin K-dependent incorporation of 
r4C02 was measured in the absence of detergent in 
a similar way to [2]. Unless stated otherwise, 
vitamin K was used in its reduced form. 
2. MATERIALS AND METHODS 
2.1. Chemicals 3. RESULTS 
Vitamin K was obtained from Hoffmann-La 
Roche and vitamin K hydroquinone was prepared 
as in [2]. Warfarin and dithiothreitol were obtained 
from Sigma and the pentapeptide Phe-Leu- 
Glu-Glu-Leu (FLEEL) from Vega Fox. 
NaHt4C03 (40 Ci/mol) was purchased from New 
3.1. Detection of vitamin K-dependent systems in 
various tissues 
A 3-week-old calf was anticoagulated by oral 
administration of warfarin (1.5 g daily) for 1 week. 
After this period the animal was slaughtered and 
the various organs were excised and homogenized 
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as in section 2. The amounts of vitamin K-depen- 
dent carboxylase present in the respective microso- 
ma1 fractions were measured in the presence of an 
excess of exogenous ubstrate and are expressed as 
a percentage of the amount of carboxylase in liver. 
The results are summarized in table 1. 
Table 1 
Amounts of microsomal carboxylase and endogenous 
substrate in various tissues 
Tissue Amount of Amount of endogenous 
carboxylase (970) substrate (W) 
Liver 
Testis 
Kidney 
Spleen 
Lung 
Thyroid 
Pancreas 
Thymus 
Heart muscle 
Skeletal muscle 
Diaphragm 
Arteries 
Veins 
Lymphocytes 
Bone marrow 
Cartilage 
Bone 
Bone membrane 
Tendon 
(Uterus) 
100 
210 
73 
70 
63 
31 
11 
11 
0 
0 
0 
62 
0 
0 
10 
40 
25 
0 
100 
130 
12 
41 
6 
7 
6 
3 
0 
0 
0 
10 
0 
0 
30 
16 
8 
0 
35 
(6) 
The amounts of carboxylase were measured as the maxi- 
mal rate of carboxylation of endogenous + exogenous 
(FLEEL, 10 mM) substrate and are expressed per mg 
microsomal protein (cf. 121). In liver this value was 
0.95 pmol CO1 incorporated . min-t . mg protein-t. The 
amounts of endogenous substrate were measured as the 
total amount of CO2 that could be incorporated into 
trichloroacetic acid-precipitable material. In liver this 
value was 35 pmol COz/mg microsomal protein. In both 
cases the amounts in liver were arbitrarily considered to 
be 100%. The data for uterine tissue were obtained from 
a female animal with comparable characteristics of car- 
boxylase from liver, spleen and kidney. Because they are 
obtained from a different animal, these data are given 
in parentheses 
3.2. Characterization of the various vitamin K- 
dependent systems 
To compare the various carboxylating enzyme 
systems, we measured the KM of vitamin K hydro- 
quinone in these systems and their susceptibility to 
warfarin. The latter was accomplished by estab- 
lishing the warfarin concentration required for 
50% inhibition of the vitamin K-driven reaction. 
The results of these experiments are summarized 
in table 2. 
3.3. Characterization of the various endogenous 
substrates 
Finally, we tried to identify the various endo- 
genous ubstrates by immunospecific adsorption of 
the carboxylated reaction products onto Sephar- 
ose-bound antibodies against prothrombin and 
clotting factor X. About 40% of the total amount of 
endogenous ubstrate in the liver could be bound 
to one of these antibodies (table 3). Most of the 
other tissues, however, also contained some mate- 
rial (lo-20%) with antigenic determinants that are 
recognized by either antiprothrombin or antifactor 
X. 
Table 2 
Characteristics of carboxylase from various tissues 
Tissue KM (PM) of [Warfarin] (PM) 
vitamin KHz required for 50% 
inhibition 
Liver 14 
Testis 11 
Kidney 7 
Spleen 8 
Lung 8 
Thyroid 7 
Thymus 8 
Arteries 16 
Cartilage 12 
Bone 11 
(Uterus) (8) 
18 
18 
2s 
13 
1.5 
16 
16 
10 
12 
The KM of vitamin K hydroquinone (KHz) was mea- 
sured as in 121. [Warfarin] required for 50% inhibition 
was measured in the presence of 25 PM vitamin K 
quinone 
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Table 3 
Immunochemical characterization of endogenous 
substrates from various tissues 
Tissue Carboxylated substrate (W) bound to: 
Antiprothrombin Antifactor X 
Liver 17.2 21.5 
Testis 10.4 6.2 
Kidney 7.0 13.1 
Spleen 5.3 8.1 
Lung 6.4 3.9 
Thyroid 9.5 1.0 
Pancreas 0 0 
Thymus 6.9 2.6 
Arteries 8.8 13.6 
(Uterus) 8.7 3.0 
Reaction mixtures (1 ml) were incubated for 1 h at 25°C 
in the presence of 50 PCi NaHt4C0s. Purified anti- 
bodies against either prothrombin or factor X were 
immobilized and used for the extraction of these 
mixtures [7] 
4. DISCUSSION 
When we screened a great number of tissues for 
the presence of carboxylase, it became clear that 
this vitamin K-dependent enzyme is present in all 
tissues except lymphocytes, veins, muscle and bone 
membrane. The other tissues that were checked 
all contained carboxylase, though in variable 
amounts. It should be kept in mind, that in all 
cases carboxylase was tested with the synthetic 
pentapeptide Phe-Leu-Glu-Glu-Leu. This pep- 
tide has been derived from prothrombin and it 
might be a poor substrate for some non-hepatic 
carboxylases, especially because we have observed 
some difference in substrate specificity between 
carboxylase obtained from liver and that from pla- 
centa (unpublished). It is quite possible therefore, 
that the data in table 1 underestimate the real 
amounts of carboxylase. We were unable to detect 
substantial differences between the various car- 
boxylase preparations with respect to the KM for 
vitamin K and the ability of the vitamin K-antago- 
nist warfarin to inhibit these systems. It seems like- 
ly therefore, that in patients receiving vitamin K- 
antagonists, the vitamin K-dependent carboxylases 
in all tissues will probably be inhibited to the same 
extent. In an attempt to characterize the carboxyl- 
ated substrates, present in a number of tissues, we 
extracted carboxylating reaction mixtures with 
Sepharose-bound antibodies against prothrombin 
and factor X. As might be expected, the endo- 
genous substrate in the liver had more antigenic 
determinants in common with these two clotting 
factors than had the substrates from other tissues. 
Nevertheless, except for the pancreas they all had 
some affinity towards the Sepharose-bound anti- 
bodies, although to a variable extent. Since it 
seems unlikely that coagulation factors are pro- 
duced by all these tissues, we think that in most 
cases the affinity of the various substrates towards 
the antibodies is caused by a certain amino acid 
sequence which they have in common with the 
clotting factors and which might serve as a recog- 
nition site for carboxylase. 
It is tempting to speculate about the function of 
the non-hepatic vitamin K-dependent proteins, 
but conclusions have to be drawn with great care. 
However, we are inclined to make some critical 
remarks. In the first place, it is surprising that only 
few side-effects are known in patients who under- 
go long-term oral anticoagulant therapy. Of course 
this may be an indication that most vitamin K- 
dependent processes (except for their role in the 
maturation of coagulation factors) are rather un- 
important reactions, which can be blocked without 
further damage for the organism. On the other 
hand, it remains possible that side-effects of anti- 
coagulant herapy are obscured by secondary rea- 
sons. The high amount of carboxylase in testis, for 
instance, suggests that vitamin K is involved in the 
synthesis of a sperm protein (for instance acrosin, a 
trypsin-like serine protease which has many sim- 
ilarities with prothrombin and which is required 
for the penetration of the sperm cell into the ovum 
[S]). During long-term anticoagulation, the syn- 
thesis of such a vitamin K-dependent protein 
would be inhibited, possibly resulting in an 
impaired production of active sperm cells. Most 
patients treated with vitamin K-antagonists are 
over 50 years old, and maybe for this reason their 
fertility has never been checked (at least as far as 
we know). 
A second striking observation was the difference 
in the carboxylase content between arteries and 
veins. The protein(s) produced by arterial carbox- 
ylase might be involved in the calcification of the 
vessel wall (which occurs almost exclusively in the 
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arteries) or in the formation of hardened athero- 
sclerotic plaque (in which a Gla-containing protein 
has been detected [9]). A possible dominant role of 
this protein in thrombus formation would be 
obscured for the following reasons. High-risk pa- 
tients (for instance those who suffered from myo- 
cardial infarction) are generally kept on oral anti- 
coagulant therapy, because it has been demon- 
strated that the therapy reduced the risk of rein- 
farction [lo]. Is it believed that the reduced risk is 
related to the reduced plasma concentration of the 
vitamin K-dependent clotting factors. However, 
during antivitamin K treatment also the produc- 
tion of the arterial vitamin K-dependent protein(s) 
is reduced and this reduction might be of much 
greater importance than the reduced concentration 
of coagulation factors. 
Since at present we can only guess at the func- 
tion of the various non-hepatic vitamin K-depen- 
dent proteins it seems important that they are pu- 
rified and further characterized. Possibly this will 
lead to the detection of their role in a number of 
biological processes. 
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